Home » Authors » Nuala Moran

Articles by Nuala Moran

ReGen’s Phase IIa Interim Data Not Significant In Alzheimer’s

March 27, 2002

Cyclacel, University Of Edinburgh Form Drug Design Collaboration

March 27, 2002

Avidex Platform Creates TCRs; Company Planning Partnerships

March 27, 2002

Cyclacel, University Of Edinburgh Form Drug Design Collaboration

March 27, 2002

Avidex Platform Creates TCRs; Company Planning Partnerships

March 27, 2002

ReGen’s Phase IIa Interim Data Not Significant In Alzheimer’s

March 27, 2002

Vernalis Seeks Second Nasdaq Listing, Reports Profitability

March 27, 2002

PPL’s AAT Facing Further Delays; Launch Pushed Back

March 20, 2002

Powderject Sells Needle-Free Drug Delivery Business To AlgoRx

March 20, 2002

OGS, BioInvent In Three-Year Therapeutic Antibodies Deal

March 20, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...